Where does Gyroscope Therapeutics Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Gyroscope Therapeutics Limited ranks #17,726 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Gyroscope Therapeutics Limited hold?

Gyroscope Therapeutics Limited holds 16 US utility patents granted between 2020 and 2024, spanning 4 technology areas.

What is Gyroscope Therapeutics Limited's Innovation Score?

Gyroscope Therapeutics Limited has an Innovation Score of 39.1 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Gyroscope Therapeutics Limited's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Gyroscope Therapeutics Limited.

What does claim depth mean for Gyroscope Therapeutics Limited's patents?

Gyroscope Therapeutics Limited's patents average 18.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Gyroscope Therapeutics Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Gyroscope Therapeutics Limited

Q: What technology areas does Gyroscope Therapeutics Limited focus on?

Gyroscope Therapeutics Limited's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 16 patents, ranking #398 of 3,082 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 16 granted patents across 4 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gyroscope ranks #17,726 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 4 technology areas.

#17,726
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.1/100): 18.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R17726 · Foreign Corporation #17,726 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 16 grants
MID-PACK #17,726/49,997
PHOTO-FINISH Grindmaster
CPC-NARROW A61F · 4 areas
INNOV-THIN 39.1/100
CLAIMS-RICH 18.6 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Grindmaster Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Gyroscope’s 39.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (25%) Velocity 11.1 pts (28%) Breadth 7.1 pts (18%) Claim depth 11.2 pts (29%)

Qualcomm Incorporated · highest

85
Gyroscope Therapeutics · this assignee

39
3D Lighting… · lowest

7

What this shows Gyroscope's Innovation Score is 39.1/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Gyroscope?

Each dot is one of Gyroscope’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Gyroscope’s own 18.6 claims/patent is ABOVE the 9.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Gyroscope vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Gyroscope's grants concentrate

Gyroscope Therapeutics Limited is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (5 grants) versus a trough of 2 in 2024. By volume, Gyroscope sits between Grindmaster Corporation and Hass Corporation.

Gyroscope's three-year grant acceleration

Gyroscope Therapeutics Limited shows 10 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Grindmaster

16
Guangzhou Fengsen…

16
Guardtime

16
Gunitech

16
Hale Products

16
Hangzhou Silan Mi…

16
Hanwha Q Cells

16
Hass

16
Gyroscope Therape… ◀

16

What this shows Gyroscope holds 16 patents at rank #17,724, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Gyroscope

By rank, the assignees closest to #17,724 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Gyroscope's primary technology class.

Gyroscope's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Gyroscope Therapeutics Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	3	18.8%
2021	3	18.8%
2022	3	18.8%
2023	5	31.3%
2024	2	12.5%

Which technologies does Gyroscope Therapeutics Limited patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 16

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 14

A61B - DIAGNOSIS; SURGERY; Identification 2

G05G - Control Devices OR Systems Insofar AS Characterised BY Mechanical Features Only 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Gyroscope Therapeutics Limited's patent record in context - here's where to go next.

Gyroscope Therapeutics Limited's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #17,726 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Gyroscope Therapeutics Limited against Grindmaster Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.